Sorry - There were no pages found that contain that search phrase.
 |
|
|
|
|
|
Previous 25 Showing Treatment 26 to 50 of 91 Next 25 |
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Zanesville, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
|
|
Details |
|
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
|
Columbus, OH USA |
|
04/11/2008 |
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Columbus, OH USA |
|
03/01/2008 |
|
|
|
|
|
Details |
|
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
|
Columbus, OH USA |
|
03/01/2008 |
|
|
|
Details |
|
Identification of factors associated with brain metastasis in women with breast cancer: development of a predictive nomogram |
|
Cleveland, OH USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Identification of Hypermethylated Serum Tumor DNA in High Grade Glioma Patients and Correlation with Magnetic Resonance Imaging Findings |
|
Cleveland, OH USA |
|
08/18/2007 |
|
|
|
Details |
|
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
|
Columbus, OH USA |
|
08/18/2007 |
|
|
|
|
|
Details |
|
Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Evaluation of a Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase I Evaluation of Sodium Stibogluconate in Combination With Interferon a-2b for Solid Tumors, Lymphoma or Myeloma |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Trial of Continuous Dose Temozolomide in Patients With Newly Diagnosed Pure and Mixed Anaplastic Oligodendroglioma |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Trial of Patupilone in Patients With Brain Metastases From Breast Cancer |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
|
Columbus, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Phase II Randomized Study of Intra-Arterial Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Delayed High-Dose Sodium Thiosulfate in Patients With High-Grade Glioma |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Phase III Randomized Study of Radiotherapy Combined With Temozolomide Versus Carmustine in Patients With Anaplastic Astrocytoma or Mixed Gliomas
|
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas |
|
Akron, OH USA |
|
05/01/2007 |
|
|
|
Details |
|
A Phase I/II Study Utilizing the Zeiss INTRABEAM System for the Treatment of a Resected Solitary Brain Metastasis |
|
Cleveland, OH USA |
|
05/01/2007 |
|
|
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Cleveland, OH |
|
05/01/2007 |
|
|
|
Details |
|
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
|
Akron, OH USA |
|
05/01/2007 |
|
|
|
|
|
